Sun Kyoung Lee
Overview
Explore the profile of Sun Kyoung Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kang E, Lee S, Park K, Son S, Kim K, Chung W
Evid Based Complement Alternat Med
. 2018 Jan;
2017:1583185.
PMID: 29333179
Once breast cancer cells grow aggressively and become lodged in the skeleton through migration and invasion, they interact with bone microenvironment and accelerate much more tumor growth and bone destruction....
12.
Lee S, Kim H, Park J, Kim H, Kim K, Son S, et al.
Sci Rep
. 2017 Dec;
7(1):17332.
PMID: 29230013
The activities of osteoclasts and osteoblasts are balanced to maintain normal bone density. Many pathological conditions cause osteoclastic bone resorption in excess of osteoblastic bone formation, resulting in osteoporosis. We...
13.
Lee S, Park K, Kim H, Park J, Son S, Kim K, et al.
Sci Rep
. 2017 Aug;
7(1):9610.
PMID: 28851919
Breast cancer mainly spreads to bone, causing decreased survival of patient. Human antigen R (HuR) and chemokines are important molecules associated with mRNA stability and cell-cell interaction in cancer biology....
14.
Kim H, Park K, Chung W, Lee S, Kim K
J Cancer Prev
. 2017 Apr;
22(1):22-32.
PMID: 28382283
Background: Nicotine is a major toxic component of tobacco smoke and has been recognized as a risk factor to induce oxidative tissue damage, which is a precursor to cardiovascular diseases,...
15.
Park J, Kim H, Kim K, Lee S, Kim H, Park K, et al.
Oncotarget
. 2016 Dec;
8(6):9079-9092.
PMID: 28030842
High recurrence and lower survival rates in patients with oral squamous cell carcinoma (OSCC) are associated with its bone invasion. We identified the oncogenic role of RUNX3 during bone invasion...
16.
Kim Y, Lee S, Park K, Chung W
J Cancer Prev
. 2016 Jul;
21(2):88-94.
PMID: 27390737
Background: Breast cancer is the most common malignant disease in women. The patients with advanced breast cancer develop metastasis to bone. Bone metastasis and skeletal-related events by breast cancer are...
17.
Lee S, Park K, Kim K, Kim H, Chung W
J Cancer Prev
. 2016 Jan;
20(4):281-6.
PMID: 26734591
Bone destruction induced by the metastasis of breast cancer cells is a frequent complication that is caused by the interaction between cancer cells and bone cells. Receptor activator of nuclear...
18.
Kim H, Park J, Lee S, Kim K, Park K, Chung W
J Pathol
. 2015 Aug;
237(4):520-31.
PMID: 26239696
Non-small cell lung cancer (NSCLC) frequently metastasizes to bone, which is associated with significant morbidity and a dismal prognosis. RUNX3 functions as a tumour suppressor in lung cancer and loss...
19.
Lee S, Park K, Kim H, Kim K, Kang E, Kim Y, et al.
Cell Physiol Biochem
. 2015 Jul;
36(5):1809-20.
PMID: 26184636
Background: Metastatic breast cancer cells are frequently associated with osteoclast-mediated bone resorption, resulting in severe bone destruction and increased mortality in patients. Platycodin D (PD) isolated from Platycodon grandiflorum is...
20.
Shin J, Kim H, Kim K, Lee S, Park J, Kim H, et al.
Evid Based Complement Alternat Med
. 2015 Apr;
2015:582437.
PMID: 25892999
Many osteopenic disorders, including a postmenopausal osteoporosis and lytic bone metastasis in breast and prostate cancers, are linked with a hyperosteoclast activity due to increased receptor activator of nuclear factor...